X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1241) 1241
Conference Proceeding (79) 79
Publication (40) 40
Patent (38) 38
Book Review (37) 37
Book Chapter (33) 33
Book / eBook (21) 21
Web Resource (4) 4
Paper (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (528) 528
humans (354) 354
female (294) 294
male (269) 269
polymer science (179) 179
medicin och hälsovetenskap (178) 178
medical and health sciences (176) 176
animals (138) 138
child (122) 122
aged (114) 114
middle aged (110) 110
endocrinology & metabolism (108) 108
natural sciences (104) 104
naturvetenskap (104) 104
engineering and technology (100) 100
pediatrics (98) 98
teknik och teknologier (97) 97
adult (92) 92
adolescent (90) 90
chemistry (90) 90
polymers (88) 88
klinisk medicin (86) 86
chemical engineering (85) 85
clinical medicine (85) 85
poly (85) 85
kemiteknik (80) 80
kemi (75) 75
polymer technologies (75) 75
polymerteknologi (75) 75
chemical sciences (74) 74
oncology (72) 72
child, preschool (71) 71
abridged index medicus (66) 66
biochemistry & molecular biology (66) 66
polymer chemistry (63) 63
polymerkemi (63) 63
cardiac & cardiovascular systems (61) 61
rats (61) 61
analysis (58) 58
children (57) 57
degradation (54) 54
time factors (53) 53
treatment outcome (47) 47
aged, 80 and over (46) 46
body height (46) 46
sweden (45) 45
polymerization (44) 44
therapy (44) 44
organic chemistry (43) 43
pediatrik (43) 43
infant, newborn (42) 42
puberty (42) 42
copolymers (40) 40
mice (39) 39
biological sciences (38) 38
epsilon-caprolactone (38) 38
polyesters (38) 38
follow-up studies (37) 37
infant (37) 37
reference values (37) 37
cancer och onkologi (35) 35
growth (35) 35
prognosis (35) 35
research (35) 35
cancer and oncology (34) 34
chemistry, multidisciplinary (34) 34
medicine (34) 34
mortality (34) 34
obesity (34) 34
ring-opening polymerization (34) 34
risk factors (34) 34
biodegradation (33) 33
growth disorders - drug therapy (33) 33
human growth hormone - therapeutic use (33) 33
hydrolysis (33) 33
chemistry, organic (32) 32
polyethylene (32) 32
aliphatic polyesters (31) 31
body weight (31) 31
final height (31) 31
insulin (31) 31
organisk kemi (31) 31
dose-response relationship, drug (30) 30
growth hormone (30) 30
weight (30) 30
body mass index (29) 29
cells (29) 29
colipase (29) 29
immunology (29) 29
kardiologi (29) 29
kinetics (29) 29
sweden - epidemiology (29) 29
cardiac and cardiovascular systems (28) 28
electric communication technique (28) 28
electricity (28) 28
lipase (28) 28
physiology (28) 28
polymer sciences (28) 28
surgery (28) 28
transmission of digital information, e.g. telegraphiccommunication (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1375) 1375
German (28) 28
Chinese (13) 13
French (12) 12
Swedish (7) 7
Spanish (6) 6
Icelandic (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher... 
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article